MetaCap

abrdn Life Sciences Investors (HQL) vs Nuveen New York Municipal Value Fund (NNY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 24.7x for Nuveen New York Municipal Value Fund). abrdn Life Sciences Investors offers the higher dividend yield (10.96% vs 4.48%).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HQL-0.74%NNY+0.13%
+0%-0%-1%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HQL versus NNY key metrics
MetricHQLNNY
Share price$17.43$7.90
1-day change-0.74%+0.13%
YTD return+3.87%—
1-year return+9.07%—
5-year return-15.63%—
P/E ratio (TTM)2.6324.69
EPS (TTM)$6.64$0.32
Dividend yield10.96%4.48%
Annual dividend$1.91$0.354
52-week high$22.67$8.94
52-week low$15.66$7.55
Distance from 52-week high-23.11%-11.63%
Average volume146.74K52.34K
SectorFinanceFinance
IndustryInvestment ManagersInvestment Managers

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Nuveen New York Municipal Value Fund trades at a higher earnings multiple (24.7x vs 2.6x trailing P/E).
  • abrdn Life Sciences Investors offers a meaningfully higher dividend yield (10.96% vs 4.48%).

About abrdn Life Sciences Investors

HQL stock →

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.

Finance · Investment Managers

HQL vs NNY FAQ

Which has the lower P/E ratio, HQL or NNY?

HQL has the lower trailing P/E at 2.6, versus 24.7 for NNY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, abrdn Life Sciences Investors or Nuveen New York Municipal Value Fund?

abrdn Life Sciences Investors has the higher yield at 10.96%, compared with 4.48% for Nuveen New York Municipal Value Fund.

Are abrdn Life Sciences Investors and Nuveen New York Municipal Value Fund in the same industry?

Yes. Both are classified in the Investment Managers industry within the Finance sector.

More comparisons